Cargando…
Patient visits and prescriptions for attention-deficit/hyperactivity disorder from 2017–2021: Impacts of COVID-19 pandemic in primary care
OBJECTIVE: To determine whether more patients presented with Attention-deficit/hyperactivity disorder (ADHD)-related visits and/or sought care from family physicians more frequently during the COVID-19 pandemic. METHODS: Electronic medical records from the University of Toronto Practice-Based Resear...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010552/ https://www.ncbi.nlm.nih.gov/pubmed/36913355 http://dx.doi.org/10.1371/journal.pone.0281307 |
_version_ | 1784906198272704512 |
---|---|
author | Butt, Debra A. Stephenson, Ellen Kalia, Sumeet Moineddin, Rahim Tu, Karen |
author_facet | Butt, Debra A. Stephenson, Ellen Kalia, Sumeet Moineddin, Rahim Tu, Karen |
author_sort | Butt, Debra A. |
collection | PubMed |
description | OBJECTIVE: To determine whether more patients presented with Attention-deficit/hyperactivity disorder (ADHD)-related visits and/or sought care from family physicians more frequently during the COVID-19 pandemic. METHODS: Electronic medical records from the University of Toronto Practice-Based Research Network were used to characterize changes in family physician visits and prescriptions for ADHD medications. Annual patient prevalence and visit rates pre-pandemic (2017–2019) were used to calculate the expected rates in 2020 and 2021. The expected and observed rates were compared to identify any pandemic-related changes. RESULTS: The number of patients presenting for ADHD-related visits during the pandemic was consistent with pre-pandemic trends. However, observed ADHD-related visits in 2021 were 1.32 times higher than expected (95% CI: 1.05–1.75), suggesting that patients visited family physicians more frequently than before the pandemic. CONCLUSION: Demand for primary care services related to ADHD has continued to increase during the pandemic, with increased health service use among those accessing care. |
format | Online Article Text |
id | pubmed-10010552 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-100105522023-03-14 Patient visits and prescriptions for attention-deficit/hyperactivity disorder from 2017–2021: Impacts of COVID-19 pandemic in primary care Butt, Debra A. Stephenson, Ellen Kalia, Sumeet Moineddin, Rahim Tu, Karen PLoS One Research Article OBJECTIVE: To determine whether more patients presented with Attention-deficit/hyperactivity disorder (ADHD)-related visits and/or sought care from family physicians more frequently during the COVID-19 pandemic. METHODS: Electronic medical records from the University of Toronto Practice-Based Research Network were used to characterize changes in family physician visits and prescriptions for ADHD medications. Annual patient prevalence and visit rates pre-pandemic (2017–2019) were used to calculate the expected rates in 2020 and 2021. The expected and observed rates were compared to identify any pandemic-related changes. RESULTS: The number of patients presenting for ADHD-related visits during the pandemic was consistent with pre-pandemic trends. However, observed ADHD-related visits in 2021 were 1.32 times higher than expected (95% CI: 1.05–1.75), suggesting that patients visited family physicians more frequently than before the pandemic. CONCLUSION: Demand for primary care services related to ADHD has continued to increase during the pandemic, with increased health service use among those accessing care. Public Library of Science 2023-03-13 /pmc/articles/PMC10010552/ /pubmed/36913355 http://dx.doi.org/10.1371/journal.pone.0281307 Text en © 2023 Butt et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Butt, Debra A. Stephenson, Ellen Kalia, Sumeet Moineddin, Rahim Tu, Karen Patient visits and prescriptions for attention-deficit/hyperactivity disorder from 2017–2021: Impacts of COVID-19 pandemic in primary care |
title | Patient visits and prescriptions for attention-deficit/hyperactivity disorder from 2017–2021: Impacts of COVID-19 pandemic in primary care |
title_full | Patient visits and prescriptions for attention-deficit/hyperactivity disorder from 2017–2021: Impacts of COVID-19 pandemic in primary care |
title_fullStr | Patient visits and prescriptions for attention-deficit/hyperactivity disorder from 2017–2021: Impacts of COVID-19 pandemic in primary care |
title_full_unstemmed | Patient visits and prescriptions for attention-deficit/hyperactivity disorder from 2017–2021: Impacts of COVID-19 pandemic in primary care |
title_short | Patient visits and prescriptions for attention-deficit/hyperactivity disorder from 2017–2021: Impacts of COVID-19 pandemic in primary care |
title_sort | patient visits and prescriptions for attention-deficit/hyperactivity disorder from 2017–2021: impacts of covid-19 pandemic in primary care |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10010552/ https://www.ncbi.nlm.nih.gov/pubmed/36913355 http://dx.doi.org/10.1371/journal.pone.0281307 |
work_keys_str_mv | AT buttdebraa patientvisitsandprescriptionsforattentiondeficithyperactivitydisorderfrom20172021impactsofcovid19pandemicinprimarycare AT stephensonellen patientvisitsandprescriptionsforattentiondeficithyperactivitydisorderfrom20172021impactsofcovid19pandemicinprimarycare AT kaliasumeet patientvisitsandprescriptionsforattentiondeficithyperactivitydisorderfrom20172021impactsofcovid19pandemicinprimarycare AT moineddinrahim patientvisitsandprescriptionsforattentiondeficithyperactivitydisorderfrom20172021impactsofcovid19pandemicinprimarycare AT tukaren patientvisitsandprescriptionsforattentiondeficithyperactivitydisorderfrom20172021impactsofcovid19pandemicinprimarycare |